Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants

Viral Immunology

Volumn 21, Issue 2, 2008, Pages 163-172

  Gans, Hayley A ^a   Yasukawa, Linda L ^a   Zhang, Cathryn Z ^a   Wakim, Rima Hanna ^a   Rinki, Mary ^a   Dehovitz, Ross ^b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 15;

ADULT; ANTIGEN EXPRESSION; CAUSE OF DEATH; CELL CULTURE; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GROUPS BY AGE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; INFANT; INTERFERON PRODUCTION; MEASLES; MEASLES VACCINATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; SINGLE DRUG DOSE; T LYMPHOCYTE; TREATMENT RESPONSE;

ADULT; AGE FACTORS; CD40 LIGAND; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; LEUKOCYTES, MONONUCLEAR; MEASLES; MEASLES VACCINE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 45749116533     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0113     Document Type: Conference Paper

References (65)

1. Aaby P, Andersen M, and Knudsen K: Excess mortality after early exposure to measles. Int J Epidemiol 1993;22: 156-162.
2. Aaby P, Clements J, and Orinda V: Presented at the Expanded Programme on Immunization, Geneva, 1991.
3. Atabani SF, Byrnes AA, Jaye A, Kidd IM, Magnusen AF, Whittle H, and Karp CK: Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 2001;184:1-9.
4. Avice MN, Demeure CE, Delespesse G, Rubio M, Armant M, and Sarfati M: IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. J Immunol 1998; 161:3408-3415.
5. Banchereau J, Bazan F, Blanchard D, et al.: The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
6. Banchereau J, and Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
7. Centers for Disease Control and Prevention: Epidemiology of measles - United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2004;53:713-716.
8. Centers for Disease Control and Prevention: Global measles control and regional elimination, 1998-1999. MMWR Morb Mortal Wkly Rep 1999;48:1124-1130.
9. Centers for Disease Control and Prevention: Measles - United States, 2005. MMWR Morb Mortal Wkly Rep 2006; 55:1348-1351.
10. Centers for Disease Control and Prevention: Progress in reducing global measles deaths, 1999-2004. MMWR Morb Mortal Wkly Rep 2006;55:247-249.
11. Centers for Disease Control and Prevention: Update: Global measles control and mortality reduction - worldwide, 1991-2001. MMWR Morb Mortal Wkly Rep 2003;52:471-475.
12. Chehimi J, and Trinchieri G: Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 1994;14:149-161.
13. Clements CJ, and Cutts FT: The epidemiology of measles: thirty years of vaccination. Curr Top Microbiol Immunol 1995;191:13-33.
14. Durandy A, De Saint Basile G, Lisowska-Grospierre B, et al.: Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol 1995;154:1560-1568.
15. Erkeller-Yuksel FM, Deneys V, Yuksel B, et al.: Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120:216-222.
16. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, and Rabourdin-Combe C: Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186: 813-823.
17. Fuleihan R, Ahern D, and Geha RS: Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur J Immunol 1994;24:1925-1928.
18. Gans H, Arvin A, Galinus J, Logan L, DeHovitz R, and Maldonado Y: Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998;280:527-532.
19. Gans H, Maldonado Y, Yasukawa L, Beeler J, Rinki M, DeHovitz R, and Arvin A: Interleukin 12, interferon-g and T cell proliferation to measles in immunized infants. J Immunol 1999;162:5569-5575.
20. Gans H, Yasukawa L, Alderson A, et al.: Humoral and cell-mediated immune responses to an early two-dose measles vaccination regimen in the United States. J Infect Dis 2004;190:83-90.
21. Gehrz RC, Linner KM, Christianson WR, Ohm AE, and Balfour HH Jr.: Cytomegalovirus infection in infancy: virological and immunological studies. Clin Exp Immunol 1982;47:27-33.
22. Gehrz RC, Marker SC, and Balfour HH Jr.: Specific cell-mediated immune defect in congenital cytomegalovirus infection. Lancet 1977;1:811-812.
23. Gehrz RC, Peterson ES, and Liu YN: Immune mechanisms in congenital cytomegalovirus infection: activation of CMV-specific T helper cells (CMV-Th) by exogenous IL-2. Clin Exp Immunol 1988;74:333-338.
24. Griffin DE: Immune responses during measles virus infection. Curr Top Microbiol Immunol 1995;191:117-134.
25. Griffin DE, Moench TR, Johnson RT, Lindo de Soriano I, and Vaisberg A: Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin Immunol Immunopathol 1986;40:305-312.
26. Griffin DE, and Ward BJ: Differential CD4 T cell activation in measles. J Infect Dis 1993;168:275-281.
27. Griffin DE, Ward BJ, and Esolen LM: Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 1994;170(Suppl 1):S24-S31.
28. Griffin DE, Ward BJ, Jauregui E, Johnson RT, and Vaisberg A: Immune activation in measles. N Engl J Med 1989;320:1667-1672.
29. Hanshaw JB: Congenital cytomegalovirus infection: a fifteen year perspective. J Infect Dis 1971;123:555-561.
30. Hasan MS, Kallas EG, Thomas EK, Looney J, Campbell M, and Evans TG: Effects of interleukin-15 on in vitro human T cell proliferation and activation. J Interferon Cytokine Res 2000;20:119-123.
31. Hassan J, Dooley S, and Hall W: Immunological response to cytomegalovirus in congenitally infected neonates. Clin Exp Immunol 2007;147:465-471.
32. Heufler C, Koch F, Stanzl U, et al.: Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996;26:659-668.
33. Hulstaert F, Hannet I, Deneys V, Munhyeshuli V, Reichert T, De Bruyere M, and Strauss K: Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol 1994;70:152-158.
34. Ildirim I, Sapan N, and Cavusoglu B: Comparison of BCG vaccination at birth and at third month of life. Arch Dis Child 1992;67:80-82.
35. Jullien P, Cron RQ, Dabbagh K, et al.: Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation. Int Immunol 2003;15:1461-1472.
36. Karp CL, Wysocka M, Wahl LM, et al.: Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996;273:228-231.
37. Lewis D, and Wilson C: Developmental Immunology and Role of the Host Defenses in Neonatal Susceptibility to Infection, 4th ed. Saunders, Philadelphia, 1995.
38. Mackey MF, Barth RJ Jr., and Noelle RJ: The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 1998;63:418-428.
39. Markowitz LE, Sepulveda J, Diaz-Ortega JL, et al.: Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines [published erratum appears in N Engl J Med 1990;322:863]. N Engl J Med 1990;322:580-587.
40. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, and Umetsu DT: IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 1995;155:111-117.
41. Mbawuike IN, Piedra PA, Cate TR, and Couch RB: Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J Med Virol 1996; 50:105-111.
42. McDyer JF, Li Z, John S, Yu X, Wu CY, and Ragheb JA: IL-2 receptor blockade inhibits late, but not early, IFNgamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. J Immunol 2002;169: 2736-2746.
43. Mori A, Suko M, Kaminuma O, et al.: IL-15 promotes cytokine production of human T helper cells. J Immunol 1996;156:2400-2405.
44. Murphy MD, Brunell PA, Lievens AW, and Shehab ZM: Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics 1984;74:90-93.
45. Murray C, Lopez A, Mathers C, and Stein C: The global burden of disease 2000 project: aims, methods, and data sources. Global Programme on Evidence for Health Policy. Geneva, WHO 2001;11:10-49.
46. Naniche D, and Oldstone MB: Generalized immunosuppression: how viruses undermine the immune response. Cell Mol Life Sci 2000;57:1399-1407.
47. Noelle RJ: CD40 and its ligand in host defense. Immunity 1996;4:415-419.
48. Nonoyama S, Penix LA, Edwards CP, et al.: Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest 1995;95:66-75.
49. Pabst HF, Spady DW, Carson MM, Krezolek MP, Barreto L, and Wittes RC: Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Vaccine 1999;17:1910-1918.
50. Polack FP, Hoffman SJ, Moss WJ, and Griffin DE: Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles. J Infect Dis 2002;185:13-19.
51. Prescott SL, Taylor A, King B, Dunstan J, Upham JW, Thornton CA, and Holt PG: Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy 2003;33:566-572.
52. Schnorr JJ, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, and Schneider-Schaulies S: Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA 1997;94:5326-5331.
53. Skov S, Bonyhadi M, Odum N, and Ledbetter JA: IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells. J Immunol 2000;164:3500-3505.
54. Splawski JB, and Lipsky PE: CD40-mediated regulation of human B-cell responses. Res Immunol 1994;145:226-234; discussion 244-249.
55. Stern AS, Magram J, and Presky DH: Interleukin-12 an integral cytokine in the immune response. Life Sci 1996;58: 639-654.
56. Stuber E, Strober W, and Neurath M: Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996;183:693-698.
57. Tu W, Chen S, Sharp M, et al.: Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 2004;172: 3260-3267.
58. Upham JW, Lee PT, Holt BJ, et al.: Development of interleukin-12- producing capacity throughout childhood. Infect Immun 2002;70:6583-6588.
59. Van Kooten C, and Banchereau J: CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996; 61:1-77.
60. Ward BJ, and Griffin DE: Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 1993;67:171-177.
61. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, and Griffin DE: Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 1991;61:236-248.
62. Wasik TJ, Jagodzinski PP, Hyjek EM, Wustner J, Trinchieri G, Lischner HW, and Kozbor D: Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J Immunol 1997;158:6029-6036.
63. Wilson C: Immunologic basis of increased susceptibility of the neonate to infection. J Pediatr 1986;108:1-12.
64. Wilson CB, Westall J, Johnston L, Lewis DB, Dower SK, and Alpert AR: Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 1986;77:860-867.
65. Zweiman B, Pappagianis D, Maibach H, and Hildreth EA: Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy 1971;40:834-841.